About ASC Therapeutics
ASC Therapeutics is a company based in Milpitas (United States) founded in 2019 by Ruby Yanru Chen Tsai, Ruhong Jiang, and Michael Cleary.. ASC Therapeutics offers products and services including Gene Therapy and Stem Cell Therapy. ASC Therapeutics operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Milpitas, United States
- Founders Ruby Yanru Chen Tsai, Ruhong Jiang, Michael Cleary
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Applied Stemcell Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ASC Therapeutics
ASC Therapeutics offers a comprehensive portfolio of products and services, including Gene Therapy and Stem Cell Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for rare blood disorders using gene editing
Provides stem cell treatments for intractable diseases
Unlock access to complete
Funding Insights of ASC Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ASC Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ASC Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asc Therapeutics Comparisons
Competitors of ASC Therapeutics
ASC Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asc Therapeutics
Frequently Asked Questions about ASC Therapeutics
When was ASC Therapeutics founded?
ASC Therapeutics was founded in 2019.
Where is ASC Therapeutics located?
ASC Therapeutics is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.
Who is the current CEO of ASC Therapeutics?
Ruhong Jiang is the current CEO of ASC Therapeutics. They have also founded this company.
What does ASC Therapeutics do?
ASC Therapeutics was founded in 2019 and is based in Milpitas, United States. Focus is placed on genomics-based therapeutics targeting blood disorders within the biotechnology sector. Curative products for monogenic blood disorders and related conditions are offered. A proprietary gene-editing platform called TARGATT is maintained in the preclinical stage to support these treatments. Operations emphasize innovative solutions for hematological challenges.
Who are the top competitors of ASC Therapeutics?
ASC Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does ASC Therapeutics offer?
ASC Therapeutics offers Gene Therapy and Stem Cell Therapy.